Li S, Dou H, Shi D, Yuan R, Tu P, Yuan Q
Front Cell Infect Microbiol. 2025; 15:1513177.
PMID: 40034391
PMC: 11872919.
DOI: 10.3389/fcimb.2025.1513177.
Alvaro Varela A, Aguinaga Perez A, Navascues Ortega A, Castilla Catalan J, Ezpeleta Baquedano C
Rev Esp Quimioter. 2023; 36(3):259-266.
PMID: 36966384
PMC: 10238793.
DOI: 10.37201/req/118.2022.
Sreenath K, Kabra S, Dey A, Chandolia A, Sagar T, Singh V
Microbiol Spectr. 2022; 10(4):e0158922.
PMID: 35867428
PMC: 9430479.
DOI: 10.1128/spectrum.01589-22.
Chen J, Zhang J, Lu Z, Chen Y, Huang S, Li H
Microbiol Spectr. 2022; 10(1):e0155021.
PMID: 35138173
PMC: 8826743.
DOI: 10.1128/spectrum.01550-21.
Loconsole D, De Robertis A, Sallustio A, Centrone F, Morcavallo C, Campanella S
Infect Dis Rep. 2021; 13(3):811-820.
PMID: 34562998
PMC: 8482213.
DOI: 10.3390/idr13030073.
Macrolide Resistance, Clinical Features, and Cytokine Profiles in Taiwanese Children With Infection.
Wu T, Wang N, Liu F, Pan H, Huang F, Fang Y
Open Forum Infect Dis. 2021; 8(9):ofab416.
PMID: 34557557
PMC: 8454522.
DOI: 10.1093/ofid/ofab416.
Increased Macrolide Resistance Rate of M3562 Correlated With Macrolide Usage and Genotype Shifting.
Wang Y, Xu B, Wu X, Yin Q, Wang Y, Li J
Front Cell Infect Microbiol. 2021; 11:675466.
PMID: 34055671
PMC: 8149950.
DOI: 10.3389/fcimb.2021.675466.
Risk factors for delayed radiographic resolution in children with refractory pneumonia.
Yan Q, Niu W, Jiang W, Hao C, Chen M, Hua J
J Int Med Res. 2021; 49(5):3000605211015579.
PMID: 34034536
PMC: 8161875.
DOI: 10.1177/03000605211015579.
A multisite SNP genotyping and macrolide susceptibility gene method for based on MALDI-TOF MS.
Zhao F, Zhang J, Wang X, Liu L, Gong J, Zhai Z
iScience. 2021; 24(5):102447.
PMID: 33997713
PMC: 8105657.
DOI: 10.1016/j.isci.2021.102447.
Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain.
Rivaya B, Jordana-Lluch E, Fernandez-Rivas G, Molinos S, Campos R, Mendez-Hernandez M
J Antimicrob Chemother. 2020; 75(10):2752-2759.
PMID: 32653897
PMC: 7678890.
DOI: 10.1093/jac/dkaa256.
infections, 11 countries in Europe and Israel, 2011 to 2016.
Beeton M, Zhang X, Uldum S, Bebear C, Dumke R, Gullsby K
Euro Surveill. 2020; 25(2).
PMID: 31964459
PMC: 6976882.
DOI: 10.2807/1560-7917.ES.2020.25.2.1900112.
Antimicrobial susceptibility and molecular characteristics of isolates across different regions of China.
Zhao F, Li J, Liu J, Guan X, Gong J, Liu L
Antimicrob Resist Infect Control. 2019; 8:143.
PMID: 31463046
PMC: 6708159.
DOI: 10.1186/s13756-019-0576-5.
Mycoplasma pneumoniae detection in children with respiratory tract infections and influence on management - a retrospective cohort study in Switzerland.
Dierig A, Hirsch H, Decker M, Bielicki J, Heininger U, Ritz N
Acta Paediatr. 2019; 109(2):375-380.
PMID: 31168877
PMC: 7159768.
DOI: 10.1111/apa.14891.
Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Pneumonia in Children.
Ha S, Oh K, Ko K, Sun Y, Ryoo E, Tchah H
J Korean Med Sci. 2018; 33(43):e268.
PMID: 30344461
PMC: 6193889.
DOI: 10.3346/jkms.2018.33.e268.
Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016.
Qu J, Yang C, Bao F, Chen S, Gu L, Cao B
BMC Infect Dis. 2018; 18(1):335.
PMID: 30016939
PMC: 6050680.
DOI: 10.1186/s12879-018-3250-2.
Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015.
Carrim M, Wolter N, Benitez A, Tempia S, du Plessis M, Walaza S
Emerg Infect Dis. 2018; 24(3):506-513.
PMID: 29460736
PMC: 5823326.
DOI: 10.3201/eid2403.162052.
The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings.
Yang D, Chen L, Chen Z
PLoS One. 2018; 13(1):e0191951.
PMID: 29377957
PMC: 5788379.
DOI: 10.1371/journal.pone.0191951.
Pediatric clinical features of infection are associated with bacterial P1 genotype.
Fan L, Li D, Zhang L, Hao C, Sun H, Shao X
Exp Ther Med. 2017; 14(3):1892-1898.
PMID: 28962100
PMC: 5609089.
DOI: 10.3892/etm.2017.4721.
Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.
Kogoj R, Praprotnik M, Mrvic T, Korva M, Kese D
Eur J Clin Microbiol Infect Dis. 2017; 37(1):99-107.
PMID: 28948376
DOI: 10.1007/s10096-017-3106-5.
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Tanaka T, Oishi T, Miyata I, Wakabayashi S, Kono M, Ono S
Emerg Infect Dis. 2017; 23(10):1703-1706.
PMID: 28930026
PMC: 5621555.
DOI: 10.3201/eid2310.170106.